• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconDrugs

Drugs

Page 12 of 30
Researchers at SUNY Upstate Medical University found that nonmedical cannabis use—regardless of how or how often it was consumed—lowered a person’s odds of subjective cognitive decline by 96%.
MindRecreational cannabis use may lower your risk of cognitive decline, study says
By Lindsey LeakeApril 19, 2024
The Waldos
Lifestyle‘It’s a phenomenon’: How 4/20 grew organically from a group of Northern California high schoolers into marijuana’s holiday
By Gene Johnson and The Associated PressApril 19, 2024
A pharmacist assists a customer with medical marijuana.
NewslettersMillions of Americans have used medical marijuana. Is it covered by their FSAs?
By Emma BurleighApril 19, 2024
Senior man holding several prescription medications
HealthHow Medicare beneficiaries with Part D plans can help ensure their medications are covered
By Richard EisenbergApril 8, 2024
HealthALS drug will be pulled from US market after study showed patients didn’t benefit
By Matthew Perrone and The Associated PressApril 4, 2024
Tina Kotek
PoliticsOregon just officially changed its mind on decriminalizing drugs
By The Associated PressApril 1, 2024
HealthDemand for weight-loss drug Zepbound is so strong that Eli Lilly is warning patients may leave pharmacies empty-handed 
By Ike Swetlitz, Madison Muller and BloombergMarch 30, 2024
An out-of-focus person is point to their left and is standing in front of a window with the red and white Walgreens 'W' on it.
RetailWalgreens’ frail quarter goes beyond the discretionary spending dips afflicting its competitors. It’s ‘just not very good at retailing,’ analyst says
By Sasha RogelbergMarch 29, 2024
FinanceCanopy Growth faced bankruptcy prospects last year. Now its shares are surging as Germany decriminalizes cannabis
By Steve MollmanMarch 22, 2024
A person using Ozempic
RetailWegovy and Ozempic have ignited a gold rush in pharma as well as an upsurge in fake ‘skinny jabs’, leading to surge in hospitalizations
By Ashleigh Furlong and BloombergMarch 13, 2024
“Even though health insurance costs are the second-largest line item after payroll, CEOs don’t really understand it or know anything about it,” billionaire entrepreneur and Shark Tank investor Mark Cuban tells Fortune’s Lindsey Leake.
HealthMark Cuban’s $141K mistake: The Cost Plus Drugs cofounder says CEOs don’t understand health care coverage, and it’s costing them big
By Lindsey LeakeMarch 8, 2024
The Mark Cuban Cost Plus Drug Company will begin manufacturing its own medications in Dallas this week, cofounder and CEO Dr. Alex Oshmyansky announced Monday, March 4, 2024.
HealthMark Cuban’s Cost Plus Drugs will begin manufacturing its own medications this week
By Lindsey LeakeMarch 4, 2024
HealthFirst over-the-counter birth control pill in U.S. begins shipping to stores
By Matthew Perrone and The Associated PressMarch 4, 2024
Oregon Gov. Tina Kotek
PoliticsOregon is about to say nevermind to its groundbreaking law that decriminalized drugs
By Andrew DeMillo and The Associated PressMarch 4, 2024
Susan Wojcicki
TechFormer YouTube CEO’s son found dead in UC Berkeley dorm, leaving prominent Silicon Valley family ‘devastated beyond comprehension’
By Steve MollmanFebruary 18, 2024
1...
  • 10
  • 11
  • 12
  • 13
  • 14
...30
Most Popular
AI
A man let ChatGPT sell his home. It beat every agent's estimate by $100K—and closed in 5 daysAn image of a popular article
By Fortune EditorsMarch 21, 2026
Success
Covid gave us hybrid work. The Iran War might give us a four-day week—and this time, experts say it could stickAn image of a popular article
By Fortune EditorsMarch 21, 2026
Real Estate
Gen Z can’t afford a house. Some parents are choosing to fund their down payments over their college fundsAn image of a popular article
By Fortune EditorsMarch 20, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.